Cancer Research

Medical professionals are witnessing a transformative shift in oncology as new research confirms that tailoring radiation therapy to a patient's specific response to chemotherapy significantly reduces unnecessary side effects without increasing the risk of the disease returning. This evolution in

Ivan Kairatov is a distinguished Biopharma expert who has spent decades navigating the intricate intersections of medical innovation and clinical research. With a career rooted in the development of breakthrough therapies, he possesses a profound understanding of how early-stage diagnostic signals

Cardiovascular disease remains the leading cause of mortality across the globe, yet the medical landscape is currently witnessing a profound transformation in how we address the silent accumulation of arterial plaque. The traditional model of reactive care, which often prioritized intervention only

The transition from traditional stem cell therapies to more refined exosome-based treatments represents one of the most significant shifts in regenerative medicine during the middle of this decade. While stem cells offer immense healing potential, they carry inherent risks such as unwanted

The long-standing struggle against small cell neuroendocrine cancers has finally reached a pivotal turning point through the strategic exploitation of genetic dependencies. For over fifty years, patients diagnosed with these aggressive malignancies in the lungs, prostate, or ovaries faced a grim

The traditional classification of cancer based primarily on the organ where a tumor first appears is rapidly being superseded by a sophisticated genomic perspective that prioritizes the specific molecular drivers of the disease. Recent breakthroughs led by Dr. Derya Deniz Özdemir and an